CN105920205A - 一种治疗冻疮的中药酊 - Google Patents
一种治疗冻疮的中药酊 Download PDFInfo
- Publication number
- CN105920205A CN105920205A CN201610287649.5A CN201610287649A CN105920205A CN 105920205 A CN105920205 A CN 105920205A CN 201610287649 A CN201610287649 A CN 201610287649A CN 105920205 A CN105920205 A CN 105920205A
- Authority
- CN
- China
- Prior art keywords
- chilblain
- flos
- radix
- traditional chinese
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000010445 Chilblains Diseases 0.000 title claims abstract description 39
- 229940098465 tincture Drugs 0.000 title claims abstract description 20
- 241000628997 Flos Species 0.000 claims abstract description 50
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 15
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims description 29
- 206010030113 Oedema Diseases 0.000 abstract description 6
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract description 5
- 208000027418 Wounds and injury Diseases 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 210000001519 tissue Anatomy 0.000 abstract description 4
- 206010063560 Excessive granulation tissue Diseases 0.000 abstract description 2
- 210000001126 granulation tissue Anatomy 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 229960000074 biopharmaceutical Drugs 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 230000036407 pain Effects 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 15
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 230000008961 swelling Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 9
- 208000009084 Cold Injury Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 230000002595 cold damage Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 206010040943 Skin Ulcer Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 231100000019 skin ulcer Toxicity 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 6
- 210000005069 ears Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000017423 tissue regeneration Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 240000007711 Peperomia pellucida Species 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000036269 ulceration Effects 0.000 description 3
- 241000701413 Aconitum kusnezoffii Species 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 241001050829 Arnebia guttata Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001013934 Erigeron breviscapus Species 0.000 description 2
- 241000122501 Hypericum x moserianum Species 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241001506371 Kadsura Species 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000009498 luteolin Nutrition 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 208000009146 rhinoscleroma Diseases 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- SRWKSFRBHIWJSD-UHFFFAOYSA-N 6-cyclohexylhexan-1-ol Chemical compound OCCCCCCC1CCCCC1 SRWKSFRBHIWJSD-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000130784 Arnebia euchroma Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241001310717 Daphne genkwa Species 0.000 description 1
- 240000007175 Datura inoxia Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- PTNJRKBWIYNFSY-UHFFFAOYSA-N Lirinin-O-methyl-ether Natural products COc1ccc-2c(CC3N(C)CCc4cc(OC)c(OC)c-2c34)c1 PTNJRKBWIYNFSY-UHFFFAOYSA-N 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 206010048961 Localised oedema Diseases 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- RBVAFYCFAFADAG-UHFFFAOYSA-N Orientin Natural products OCC1OC(C(O)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4)C(O)C1O RBVAFYCFAFADAG-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000003782 Raynaud disease Diseases 0.000 description 1
- 208000012322 Raynaud phenomenon Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 241001534930 Thymelaeaceae Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241001312894 Trollius chinensis Species 0.000 description 1
- 241000202786 Trollius ledebouri Species 0.000 description 1
- LQSNPVIQIPKOGP-UHFFFAOYSA-N UNPD159785 Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O LQSNPVIQIPKOGP-UHFFFAOYSA-N 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000004238 acute tympanitis Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- OSQPUMRCKZAIOZ-UHFFFAOYSA-N carbon dioxide;ethanol Chemical compound CCO.O=C=O OSQPUMRCKZAIOZ-UHFFFAOYSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000739 chronic poisoning Toxicity 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 206010025226 lymphangitis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- XUHJBXVYNBQQBD-UHFFFAOYSA-N mesaconitine Natural products COC1CC(O)C2(COC)CN(C)C3C(C(C45)(OC(C)=O)C(O)C6OC)C(OC)C2C31C4CC6(O)C5OC(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- XUHJBXVYNBQQBD-GQPWXMLZSA-N molport-002-525-145 Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H]4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-GQPWXMLZSA-N 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- PEFNSGRTCBGNAN-UHFFFAOYSA-N nephrocizin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- PLAPMLGJVGLZOV-VPRICQMDSA-N orientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-VPRICQMDSA-N 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- GLBJJMFZWDBELO-UHFFFAOYSA-N pimobendane Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C=3C(CC(=O)NN=3)C)C=C2N1 GLBJJMFZWDBELO-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical compound C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 description 1
- 229930004006 tropane Natural products 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种治疗冻疮的中药酊,属于生物制药技术领域。所述治疗冻疮的中药酊,由下列质量百分比的原料制备得到:滇鸡血藤26‑38%;灯盏细辛13‑19%;金银花13‑19%;紫草9‑13%;三七8‑12%;金莲花6‑8%;芫花2‑4%;制草乌2‑4%;天然冰片0.8‑1.2%;洋金花0.8‑1.2%。本发明所述治疗冻疮的中药酊可以促进冻疮患者消除炎症水肿、改善创面微循环、促进肉芽组织增生,帮助机体迅速修复损伤组织。
Description
技术领域
本发明涉及一种治疗冻疮的中药酊,属于生物制药技术领域。
背景技术
冻疮是人体在寒冷季节遭受寒邪侵袭所引起局部或全身性损伤,表现为局部皮肤呈紫红色水肿性不规则红斑、硬结、肿胀、灼热痒痛,严重者出现水疱、溃疡。冻疮初起为局限性蚕豆至指甲盖大小紫红色肿块或硬结,边缘鲜红,中央青紫,触之冰冷,压之退色,去压后恢复较慢。自觉局部有胀感、瘙痒,遇热后更甚。冻疮加重时,夜晚奇痒,难以入睡,肿胀加剧,形成水疱。水疱破溃后流粘液形成糜烂或溃疡,经久不愈,可持续一两个月,甚至一冬。愈后还可留有色素沉着、色素减退、皮肤色素不均、疤痕、粗糙等。
冻疮是非冻结性冷伤,多发生于离心脏较远、血流较慢、血液供应较少、皮下脂肪较薄的面颊、手、足、耳、鼻尖等暴露的未稍部位。多见于冬季气温低且较为潮湿的地区。冻疮的发病率各家报道不一,全国范围各年龄段发病率一般为总人口的15%- 35%,且随每年气候变化而波动。冻疮有“一年发病,年年复发”的特点,如果不治愈,来年冬季极易复发,给人们的工作、学习和生活带来不便。
西医学认为,冻疮的发病机制是:冬季低温使某些易感者暴露部位的皮肤真皮内毛细血管和小动脉收缩,时间稍长引起组织缺氧,组织呈麻痹性扩张,小静脉瘀血,遇热后血管扩张更甚,液体外渗到组织,产生红斑水肿等冻疮症状。此外,末梢微循环畸形、植物神经功能素乱、营养不良、肢端血循环不良、贫血、内分泌障碍、慢性中毒或感染、缺乏运动、鞋袜过紧、手足部多汗、贫血及一些慢性消耗性疾病等,常为冻疮发病的诱因。冻疮的西医治疗有外用和内服两种,外用药以抗炎药、利水药以及促进局部循环的药物为主,内服药多用烟酸、硝苯地平等扩张血管药物。
冻疮古代谓之为“涿”,首见于《五十二病方》。《诸病源候论》阐明其病因病机:“为寒气伤于肌肤,搏于血气,血气壅滞,应即生疮,其疮亦掀肿而难瘥,乃至皮肉烂,谓之为冻烂疮也。”此后,便多称其为冻疮、烂冻疮。中医认为冻疮是由于素体阳气虚弱,皮肤肌肉受到寒湿之邪侵袭,气血凝滞,肌肤失养,血脉不通所致。治则宜温阳散寒、活血通络。中医治疗冻疮方法多样,包括中药内服调养、汤剂外洗、酊剂外擦、膏剂按摩等,并可辅以针灸推拿、穴位贴敷、红外线照射等物理治疗方式。
本发明具有养阴活血、温经散寒、祛腐生新、消肿止痒等多种功效,合理组方,有良好的消肿、促进冻伤创面愈合作用,可减轻炎症细胞浸润和皮下组织水肿,促进病损组织的再生修复。本发明对冻疮患者有效率高,在临床上应用疗效满意,药材来源稳定,制作工艺简便,既经济又使用方便,便于实施推广。
发明内容
本发明的目的在于提供一种治疗冻疮的中药酊,可以促进冻疮患者消除炎症水肿、改善创面微循环、促进肉芽组织增生,帮助机体迅速修复损伤组织。
本发明通过下列技术方案完成:一种治疗冻疮的中药酊,由下列质量百分比的原料制备得到:
滇鸡血藤 26-38%
灯盏细辛 13-19%
金银花 13-19%
紫草 9-13%
三七 8-12%
金莲花 6-8%
芫花 2-4%
制草乌 2-4%
天然冰片 0.8-1.2%
洋金花 0.8-1.2%。
原料均为加工好的饮片,其中冰片不能加热,容易挥发。
其中,滇鸡血藤主要来源于五味子科南五味子属内南五味子(Kadsura interiorA. C. Smith)的藤茎。性温,味苦、甘。归肝、肾经。含异性南五味子丁素等化学成分。功能:活血补血,调经止痛,舒筋通络。用于月经不调,痛经,麻木瘫痪,风湿痹痛,气血虚弱。用量:15-30g。
灯盏细辛为菊科植物短葶飞蓬Erigeron breviscapus(Vant.)Hand.-Mazz.的干燥全草。味辛、微苦,性温。归心、肝经。含有野黄芩素、芹菜素、木犀草素等化学成分。具有祛风散寒,活血通络止痛的功效。用于风寒湿痹痛,中风瘫痪,胸痹心痛。牙痛,感冒。用量:9~15g。
金银花为忍冬科植物忍冬Lonicera japonica Thunb.的干燥花蕾或带初开的花。性味与归经甘,寒。归肺、心、胃经。含有挥发油、木犀草素、环己六醇、黄酮类、肌醇、皂苷、鞣质等化学成分。功能与主治:清热解毒,疏散风热。用于痈肿疗疮,喉痹,丹毒,热毒血痢,风热感冒,温病发热。用量:6~15g。
紫草为紫草科植物新疆紫草Arnebia euchroma (Royle)Johnst.或内蒙紫草Arnebia guttata Bunge的干燥根。含色素成分及脂肪酸。味甘、咸,性寒。归心、肝经。功能与主治:清热凉血,活血解毒,透疹消斑。用于血热毒盛,斑疹紫黑,麻疹不透,疮疡,湿疹,水火烫伤。用量:5~10g。
三七为五加科植物三七Panaxnotoginseng (Burk.) F.H. Chen的干燥根和根茎。味甘、微苦,性温。归肝、胃经。皂苷成分为三七的主要有效成分。功能主治:散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛。用量:3~9g。
金莲花毛茛科植物金莲花Trollius chinensis Bunge和短瓣金莲花T.ledebouri Reichb.的花。味苦,性微寒。归肺、胃经。含有荭草苷、牡荆苷等化学成分。功能主治:清热解毒;消肿;明目。主治感冒发热、咽喉肿痛、口疮、牙龈肿痛、牙龈出血、目赤肿痛、疔疮肿毒、急性鼓膜炎、急性淋巴管炎。用量:3-6g。
芫花为瑞香科植物芫花Daphne genkwa Sieb.et Zucc.的干燥花蕾。味苦、辛,性温;有毒。归肺、脾、肾经。含香豆素类、木质素类、绿原酸类等化学成分。功能与主治:泻水逐饮;外用杀虫疗疮。用于水肿胀满,胸腹积水,痰饮积聚,气逆咳喘,二便不利;外治疥癣秃疮,痈肿,冻疮。用量:1.5~3g。
制草乌为植物北乌头Aconitum kusnezoffii Reichb.的干燥块根的炮制加工品,味辛、苦,性热;有毒。归心、肝、肾、脾经。主要化学成分为乌头碱、次乌头碱、新乌头碱等,具有祛风除湿,温经止痛的功效,用于风寒湿痹,关节疼痛,心腹冷痛,寒疝作痛,麻醉止痛。用量:1.5~3g。
天然冰片(右旋龙脑)为樟科植物樟Cinnnmomumcamphora (L.) Presl的新鲜枝、叶经提取加工制成。味辛、苦,性凉。归心、脾、肺经。功能与主治:开窍醒神,清热止痛。用于热病神昏、惊厥,中风痰厥,气郁暴厥,中恶昏迷,胸痹心痛,目赤,口疮,咽喉肿痛,耳道流脓。用量:0.3~0.9g。
洋金花为茄科植物白曼院罗Datura metel L.的花。味辛,性温,有毒。归肺、肝经。主要化学成分为莨菪烷型生物碱。功能与主治:平喘止咳,解痉定痛。用于哮喘咳嗽,脘腹冷痛,风湿痹痛,小儿慢惊;外科麻醉。用量:0.3~0.6g。
以上中药材的用量系指成人常规的一日口服剂量(数值来源于《中国药典》、《全国中草药汇编》、《中华本草》及《云南中草药》)。由于本发明为外用药,可在此基础上适当增大用量。最终,本发明以上述各味药材的口服用量上限剂量入药,这样既兼顾了有效性与安全性,又实现了用药的量化。即成人每人每日所用生药量为:滇鸡血藤30g,灯盏细辛15g,金银花15g,紫草10g,三七9g,金莲花6g,芫花3g,制草乌3g,天然冰片0.9g,洋金花0.6g。换算成百分比,即为:滇鸡血藤32%,灯盏细辛16%,金银花16%,紫草11%,三七10%,金莲花7%,芫花3%,制草乌3%,天然冰片1%,洋金花1%。中药制剂、原材料的有效成分一般允许存在±20%的偏差,故而本发明的技术方案特征扩展为:滇鸡血藤26-38%,灯盏细辛13-19%,金银花13-19%,紫草9-13%,三七8-12%,金莲花6-8%,芫花2-4%,制草乌2-4%,天然冰片0.8-1.2%,洋金花0.8-1.2%。
为了方便保存及使用,本发明被制备成酊剂,酊剂的主要溶剂为酒精,能促进有效成分渗透入肌肤,酒精又易挥发,能够把肌肤肿胀部位的多余水分带走,所以消肿快、活血效果理想,对治疗冻疮具有独特作用。
本发明所述酊剂的制备方法为常规方法。
本发明的有益效果:
中医临床治疗冻疮以温经散寒、活血化瘀、消肿止痛为主。根据这一治则,本发明选用具有养阴活血、温经散寒、祛腐生新、消肿止痒等多种功效的药材,合理组方,诸药合用,共奏逐瘀散结、消肿止痛、防腐止痒之功效、有良好的消肿、促进冻伤创面愈合作用,可减轻炎症细胞浸润和皮下组织水肿,促进病损组织的再生修复。
具体实施方式
下面结合具体实施例对本申请作进一步详细说明,但本申请的保护范围并不限于所述内容。
实施例1
本实施例所述治疗冻疮的中药酊,由下列原料制备得到:滇鸡血藤300g,灯盏细辛150g,金银花150g,紫草100g,三七90g,金莲花60g,芫花30g,制草乌30g,天然冰片9g,洋金花6g。
具体具备方法,包括以下步骤:
(1)将滇鸡血藤、灯盏细辛、金银花、紫草、三七、金莲花粉碎;然后用75%的乙醇溶液将粉碎药材润湿后装入渗漉筒中,压实后以75%的乙醇溶液进行渗滤,渗滤液减压回收至120mL备用,标记为Ⅰ号液。
(2)在芫花、制草乌、洋金花中加入75%乙醇溶液100mL,密闭浸泡5d(天),过滤,药渣再加入75%乙醇溶液80mL密闭浸泡3d;合并浸出液,加天然冰片溶解备用,标注为Ⅱ液。
(3)将Ⅰ液和Ⅱ液混合,添加75%的乙醇溶液,调整至300mL,静置3d后过滤,滤液备用。
实施例2
本实施例所述治疗冻疮的中药酊,由下列原料制备得到:滇鸡血藤350g,灯盏细辛130g,金银花130g,紫草95g,三七85g,金莲花60g,芫花30g,制草乌30g,天然冰片9g,洋金花6g。
具体具备方法,包括以下步骤:
(1)将滇鸡血藤、灯盏细辛、金银花、紫草、三七、金莲花、芫花、制草乌、洋金花粉碎;然后加入质量百分比浓度为的70%乙醇溶液1000mL常温下密闭浸渍,期间每天搅拌3次,7d后滤过。
(2)滤液减压回收至150mL左右,添加95%的乙醇溶液,调整至300mL,添入处方量的冰片,溶解,搅匀,即得治疗冻疮的中药酊。
实施例3
本实施例所述治疗冻疮的中药酊,由下列原料制备得到:取滇鸡血藤30g,灯盏细辛15g,金银花15g,紫草10g,三七9g,金莲花6g,芫花3g,制草乌3g,天然冰片0.9g,洋金花0.6g。
具体具备方法,包括以下步骤:
(1)将滇鸡血藤、灯盏细辛、金银花、紫草、三七、金莲花、芫花、制草乌、洋金花粉碎;然后加入150mL的75% 乙醇溶液,于70℃热回流3小时,过滤,合并滤液。
(2)滤液减压回收乙醇,得浸膏;以60%的乙醇溶液溶解稀释所得浸膏,调整至30mL,添入处方量的冰片,搅拌,静置,过滤,即得治疗冻疮的中药酊。
为证明本发明治疗冻疮的效果,下面以药理实验及临床效果加以说明。
对兔耳实验性冻伤的治疗作用
(1)冻伤免耳模型的制备
将家兔双耳自耳尖起至耳根处耳廓内外两侧均脱毛,脱毛后自耳尖起至5 cm 处做浸冻线标记。将兔双耳同时浸泡入-25℃的干冰乙醇溶液中,冷冻时间20s,然后取出,擦干,在空气中自然复温。冷冻后可见兔两耳发硬、苍白,继而发红肿胀,部分免耳冻区开始有渗出液、呈紫色。
(2)实验方法
取家兔10只,依照上述方法造冻伤模型,冷冻1h后开始在冻伤兔耳朵剪毛区域耳廓内外两侧均匀涂药。由于不同家兔兔耳的肿胀情况相差较大,而同一家兔左、右耳的肿胀情况较为相近。因此,以同一只兔子的一只耳作治疗,另一只耳作自身对照较为合理。在每只家免右耳涂抹实施例1~3所制酊剂0.5mL,左耳涂抹等量的45%乙醇溶液作空白对照。随后,分早、中、晚一天3次给药,连续涂抹7d后评价药物作用。
实验结果:
表1:停药后评价结果
实验结果说明本发明有较强的促进冻伤兔耳创面愈合作用,可加速兔耳中轻度冻伤的治愈。
临床治疗冻疮患者
A、一般资料
表2:患者一般资料
患者治疗前一周未曾使用其他治疗冻疮的药物。患者皮肤出现局限性水肿性紫红斑,严重时可有水疱,破溃后形成溃疡;局部有肿胀感,暖热后瘙痒,溃烂后疼痛;多发于肢端、耳廓、鼻尖等末梢部位。
B、治疗方法
先用温水将患处洗净,再用一次性无菌棉签蘸取实施例1~3所制备酊剂,反复揉擦患处,对已破溃冻疮在其边缘未破处反复涂抹直至发热。每日3次,每次用药10mL,连续2周后观察疗效。治疗期间,不使用其他冻疮治疗药物。
C、疗效标准
痊愈:红肿、疼痛、痒感消失,创面愈合;显效:局部红肿有所消退,疼痛、痒感减轻,伤口面积缩小,干燥无渗出或者有少许渗出;无效:局部红肿未好转,疼痛未减轻,伤口渗出多,面积未缩小。
D、治疗结果
表3:各实施例的治疗结果
治疗期间未发生任何不良反应。
Claims (1)
1.一种治疗冻疮的中药酊,其特征在于,由下列质量百分比的原料制备得到:滇鸡血藤26-38%;灯盏细辛13-19%;金银花13-19%;紫草9-13%;三七8-12%;金莲花6-8%;芫花2-4%;制草乌2-4%;天然冰片0.8-1.2%;洋金花0.8-1.2%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610287649.5A CN105920205A (zh) | 2016-05-04 | 2016-05-04 | 一种治疗冻疮的中药酊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610287649.5A CN105920205A (zh) | 2016-05-04 | 2016-05-04 | 一种治疗冻疮的中药酊 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105920205A true CN105920205A (zh) | 2016-09-07 |
Family
ID=56835115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610287649.5A Pending CN105920205A (zh) | 2016-05-04 | 2016-05-04 | 一种治疗冻疮的中药酊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105920205A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1813989A (zh) * | 2004-11-09 | 2006-08-09 | 谢有珠 | 1位药替硫磺速除痤疮不留疮痕与工艺植物性中草药生物 |
CN101954058A (zh) * | 2010-09-13 | 2011-01-26 | 李绪玲 | 一种治疗冻疮的药剂 |
CN102058684A (zh) * | 2010-12-16 | 2011-05-18 | 程桂芳 | 一种治疗冻疮的汤药方剂 |
CN102784375A (zh) * | 2012-07-24 | 2012-11-21 | 马千里 | 一种治疗冻疮的外用中药药剂及其制备方法 |
CN103263669A (zh) * | 2013-05-23 | 2013-08-28 | 金红叶纸业集团有限公司 | 护肤组合物及应用其的纸巾 |
-
2016
- 2016-05-04 CN CN201610287649.5A patent/CN105920205A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1813989A (zh) * | 2004-11-09 | 2006-08-09 | 谢有珠 | 1位药替硫磺速除痤疮不留疮痕与工艺植物性中草药生物 |
CN101954058A (zh) * | 2010-09-13 | 2011-01-26 | 李绪玲 | 一种治疗冻疮的药剂 |
CN102058684A (zh) * | 2010-12-16 | 2011-05-18 | 程桂芳 | 一种治疗冻疮的汤药方剂 |
CN102784375A (zh) * | 2012-07-24 | 2012-11-21 | 马千里 | 一种治疗冻疮的外用中药药剂及其制备方法 |
CN103263669A (zh) * | 2013-05-23 | 2013-08-28 | 金红叶纸业集团有限公司 | 护肤组合物及应用其的纸巾 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091258B (zh) | 一种祛除疤痕的中药组合物及其制备方法 | |
CN103751635A (zh) | 一种治疗黄褐斑的中药面膜及其制备方法 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103747779B (zh) | 毛发促生剂及其制作方法 | |
CN103330660B (zh) | 一种腰腿部护肤保健按摩膏及其制备方法 | |
CN1109554C (zh) | 一种治疗过敏性紫癜病的药 | |
CN104069474A (zh) | 一种治疗脂溢性脱发的中药组合物及其制备方法 | |
CN112076277A (zh) | 一种用于美白祛斑养颜的组合物 | |
CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
CN106039022A (zh) | 一种亮肤美白中药组合物、亮肤美白中药制剂、亮肤美白面膜、制备方法 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN102274420A (zh) | 一种治疗痤疮的中药组合物 | |
CN105617322A (zh) | 一种治疗牛皮癣的中药组合物及其制备方法 | |
CN105031254A (zh) | 一种治疗皮炎的膏剂及其制备方法 | |
CN105920205A (zh) | 一种治疗冻疮的中药酊 | |
CN104887970A (zh) | 一种针灸理疗外用药膏 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN104189362A (zh) | 一种用于治疗口腔癌的药物及制备方法 | |
CN105456708A (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
CN103127373B (zh) | 一种治疗脂溢性皮炎的中药组合物 | |
CN105770115A (zh) | 一种治疗湿疹的中药药膏 | |
CN105832618A (zh) | 能治疗皮肤病的浴盐及制法 | |
CN105748373A (zh) | 天然纯植物面膜粉 | |
CN105412395A (zh) | 一种治疗骨质增生的中药组合物及其制备方法 | |
CN113662980A (zh) | 一种保健足浴组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160907 |